Elucidating SETD2 loss-induced alterations of 3D chromatin architecture in kidney cancer metastasis

Ended Project Grant Awarded Last action

Award ID
W81XWH2110814
Recipient
Awarding agency
Obligated
$177,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
New York, NY 10065, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Sloan-Kettering Institute for Cancer Research received a $177,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2022 to elucidate alterations in three-dimensional chromatin architecture induced by SETD2 loss and their role in kidney cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield wounds. This award will advance those goals by furthering understanding of cancer metastasis, a condition with impact on both military service members and civilians.

Quick answers

Who received award W81XWH2110814?

W81XWH2110814 was awarded to Sloan-Kettering Institute For Cancer Research by Medical Command (Department of the Army) on September 1, 2021.

How much is award W81XWH2110814 worth?

$177,000 has been obligated on W81XWH2110814.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login